ALCON INC

Summary

Alcon manufactures eye care products. The Company produces and markets vitreoretinal and cataract surgery, contact lenses, and refractive technology products. Alcon serves medical industry worldwide.

Deals Overview

Total Deals6

Valued Deals6

Total Value£ 22.11 B

Avg. Deal Size£ 3.69 B

Market Context

Senior Management

David Endicott
CEO
David Murray
CFO
Timothy C. Stonesifer
CFO

Sort

aerie pharmaceuticals inc

HQ - United States

Pharmaceuticals

22 Nov 2022

Investment Date

100%

Stake

£ 650 M

Deal Value

aurion biotech

HQ - United States

Health Care Services

12 Apr 2022

Investment Date

£ 92 M

Deal Value

alcon inc

HQ - Switzerland

Medical Equipment

9 Apr 2019

Investment Date

100%

Stake

£ 20.63 B

Deal Value

Explore deals beyond your search with a free MergerLinks account.

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy